Latest News

Date Title Topic
08 Sep 2017 ESMO 2017: Invasive DFS Rates Following Trastuzumab are Improved with Neratinib Over Placebo in Early Stage HER2-positive Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
08 Sep 2017 ESMO 2017: Pembrolizumab Demonstrates Antitumour Activity in Advanced Gastric Cancer as Monotherapy and Combined with Chemotherapy Gastrointestinal cancers - Anticancer agents & Biologic therapy
08 Sep 2017 ESMO 2017 Daily Reporter
08 Sep 2017 ESMO 2017 Press Release: New Data Confirms Superiority of Docetaxel Based Triplet Therapy in Gastric Cancer Gastrointestinal cancers
08 Sep 2017 ESMO 2017 Press Release: Pembrolizumab: Promising Response Rate in Pretreated Metastatic Gastric Cancer Gastrointestinal cancers
08 Sep 2017 ESMO 2017 Press Release: Patients with High Risk Prostate Cancer May Benefit “Equally” From Two New Treatments Genitourinary cancers
08 Sep 2017 ESMO 2017 Press Release: DNA Sequencing Could Open Up New Drug Indications for Patients with Rare Cancers Translational research
08 Sep 2017 ESMO 2017 Press Release: LORELEI: Taselisib Boosts Breast Tumor Shrinkage Breast cancer
08 Sep 2017 ESMO 2017 Press Release: Rucaparib Boosts Progression-free Survival in BRCA Mutant Recurrent Ovarian Cancer Gynaecologic malignancies
07 Sep 2017 ESMO 2017 Media Alert: Get ready for ESMO 2017: Nearly 23,000 Participants Set to Attend
07 Sep 2017 ESMO 2017 Media Alert: Challenges Faced by Adolescent and Young Adult Cancer Patients: Press Conference at the ESMO 2017 Congress
07 Sep 2017 ESMO 2017 Media Alert: Incoming Wave of Biosimilars in Oncology: Special Session at ESMO 2017
06 Sep 2017 ESMO 2017 Press Release: Some Stroke Survivors May Have Underlying Cancer Epidemiology/Etiology/Cancer Prevention